Department of Molecular Medicine, University of Pavia Medical School, Pavia, Italy.
Division of Cardiology, Cardiocentro Ticino Institute, Ente Ospedaliero Cantonale (EOC), Lugano, Switzerland.
Eur J Intern Med. 2022 Feb;96:17-19. doi: 10.1016/j.ejim.2021.11.007. Epub 2021 Nov 19.
The prognostic role of procedural myocardial infarction (MI) is still controversial and matter of ongoing debate in the scientific community. A recent ESC Consensus Document confirmed the prognostic importance of type 4a MI and defined equally clinically relevant the major peri‑procedural myocardial injury, defined as the same cardiac Troponin cut-off threshold of type 4a MI without peri‑procedural angiographic complications, electrocardiographic or imaging evidence of new myocardial ischaemia. In the present manuscript we discuss available data supporting this paradigm shift and discuss some drawbacks which should be taken into account in interpreting the results. In light of recent mounting evidence, we challenge the prognostic relevance of major periprocedural myocardial injury, suggesting that type 4a MI should be the only definition for procedural MI to be used as an endpoint in clinical trials.
在科学界,程序相关性心肌梗死(MI)的预后作用仍存在争议,是一个持续争论的问题。最近的 ESC 共识文件证实了 4a 型 MI 的预后重要性,并将同样具有临床相关性的主要围手术期心肌损伤定义为与 4a 型 MI 相同的心脏肌钙蛋白截断值,但没有围手术期血管造影并发症、心电图或新心肌缺血的影像学证据。在本手稿中,我们讨论了支持这一范式转变的现有数据,并讨论了在解释结果时应考虑的一些缺陷。鉴于最近越来越多的证据,我们质疑主要围手术期心肌损伤的预后相关性,建议仅将 4a 型 MI 作为程序相关性 MI 的定义,用作临床试验的终点。